Bock v. Novartis Pharmaceuticals Corp.

OPINION

MARK R. HORNAK, District Judge.

Plaintiffs Bruce and Bonnie Bock, as personal representatives of the estate of William M. Bock (“Bock”), filed this ease against the Defendant, Novartis Pharmaceuticals Corporation (“Novartis”), alleging that Bock developed a painful and permanently disfiguring condition commonly known as osteonecrosis of the jaw (“ONJ”) as a result of using Zometa, a prescription medication designed and manufactured by Novartis for the purpose of managing metastatic bone cancer. Pending before the Court is Novartis’ Motion for Summary Judgment (ECF No. 25) aimed at the…